Promethera bags €20m for liver failure t...With a €20m financing round under its belt, Promethera Therapeutics is poised to start its Phase IIb study for its stem cell therapy treating liver failure. more ➔
Novalis Biotech closes biotech fund at €...Early-stage venture capital investor Novalis Biotech has closed its Biotech Acceleration Fund at €25m to drive growth of translational medicine start-ups. more ➔
Cellink AB to take-over Discover Echo IncSwedish Cellink AB has announced a bid of $110m to take over all shares of Discover Echo Inc., 11% of which to be paid in newly issued shares. more ➔
Rheincell set to be acquired by CatalentMajor CDMO Catalent has swallowed German RheinCell Therapeutics GmbH, an iPSC specialist, to expand its offerings in cell and gene therapies. more ➔
Data protection rules may block medical pr...In an effort to ban AI tools for facial recognition, the EU risks to block European medical geneticists to recognise genetic diseases. more ➔
NeuVasQ Biotechnologies bags €20m in Ser...NeuVasQ Biotechnologies has raised €20m through a Series A investment to advance its technology platform that restores the integrity of the blood-brain barrier in acute neurological disorders. more ➔ … more ➔
Coriolis Pharma expands its ATMP developme...Coriolis Pharma will launch operations at its currently expanded ATMP development facilities by Q4/2021. more ➔
mRNA: Evonik cooperates with Stanford Univ...Company seeks new opportunities for use of mRNA therapeutics. more ➔
COVAX: Pfizer and Biontech to provide 500... U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022. more ➔
Iksuda Therapeutics closes $47m financing... Funding to accelerate clinical progression of Iksuda’s pipeline of new generation of antibody drug conjugates, targeting tumours with high unmet need. more ➔
